BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18678790)

  • 1. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.
    Yamashita T; Yamamoto E; Kataoka K; Nakamura T; Matsuba S; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2007 Sep; 50(3):519-24. PubMed ID: 17646574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db mice.
    Fukuda M; Nakamura T; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yasuda O; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2010 Oct; 335(1):70-5. PubMed ID: 20651026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis.
    Nakamura T; Kataoka K; Fukuda M; Nako H; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):544-51. PubMed ID: 19581502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
    Nako H; Kataoka K; Koibuchi N; Dong YF; Toyama K; Yamamoto E; Yasuda O; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2012 Feb; 35(2):194-200. PubMed ID: 22089532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
    Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
    J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia.
    Sturzeneker MC; Ioshii SO; Villela Baroncini LA; Précoma DB
    Atherosclerosis; 2011 May; 216(1):97-102. PubMed ID: 21338989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice.
    Molnar J; Yu S; Mzhavia N; Pau C; Chereshnev I; Dansky HM
    Circ Res; 2005 Jun; 96(11):1178-84. PubMed ID: 15879311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.
    Kurata A; Nishizawa H; Kihara S; Maeda N; Sonoda M; Okada T; Ohashi K; Hibuse T; Fujita K; Yasui A; Hiuge A; Kumada M; Kuriyama H; Shimomura I; Funahashi T
    Kidney Int; 2006 Nov; 70(10):1717-24. PubMed ID: 16985520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects.
    Savira F; Kompa AR; Magaye R; Xiong X; Huang L; Jucker BM; Willette RN; Kelly DJ; Wang BH
    Life Sci; 2021 May; 272():119267. PubMed ID: 33631173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation.
    Yamamoto E; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Nako H; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):258-63. PubMed ID: 21059340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
    Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
    Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.
    Yokozawa J; Sasaki T; Ohwada K; Sasaki Y; Ito JI; Saito T; Kawata S
    J Gastroenterol; 2009; 44(6):583-91. PubMed ID: 19365601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
    Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
    Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways.
    Abo El-Nasr NME; Saleh DO; Mahmoud SS; Nofal SM; Abdelsalam RM; Safar MM; El-Abhar HS
    Eur J Pharmacol; 2020 May; 874():173010. PubMed ID: 32067934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.